Anti-SARS-CoV-2 Spike Glycoprotein RBD Antibody [5G8], 100 µl

The Anti-Sars-Cov-2 Spike Glycoprotein Rbd Antibody [5G8] is a crucial tool for researchers studying the SARS-CoV-2 virus, offering high specificity and sensitivity in detecting its presence. This antibody is specifically designed to target the spike glycoprotein receptor-binding domain (RBD), allowing for precise identification and analysis. Its 100 μl volume ensures efficient use in various laboratory settings.

Core Characteristics of the Anti-Sars-Cov-2 Spike Glycoprotein Rbd Antibody [5G8], 100 Μl

This polyclonal rabbit anti-SARS-CoV-2 spike glycoprotein RBD antibody [5G8] is supplied as an unconjugated IgG fraction, ideal for Western blotting, ELISA, and immunofluorescence assays. The 100 μl volume provides sufficient material for multiple experiments without the need for further dilution.

Suitable Environments

• Primary Antibodies tasks that call for Anti-Sars-Cov-2 Spike Glycoprotein Rbd Antibody [5G8] by name and pack size.
• Maintenance cycles that include Anti-Sars-Cov-2 Spike Glycoprotein Rbd Antibody [5G8] in the supply list.
• Facilities already using Primary Antibodies products comparable to Anti-Sars-Cov-2 Spike Glycoprotein Rbd Antibody [5G8].
• Operations planning around the container format shown for Anti-Sars-Cov-2 Spike Glycoprotein Rbd Antibody [5G8].